Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment

被引:107
作者
Kataoka, H
Shimomura, T
Kawaguchi, T
Hamasuna, R
Itoh, H
Kitamura, N
Miyazawa, K
Koono, M
机构
[1] Miyazaki Med Coll, Dept Pathol 2, Miyazaki 8891692, Japan
[2] Mitsubishi Tokyo Pharmaceut Inc, Yokohama Res Ctr, Aoba Ku, Yokohama, Kanagawa 2278502, Japan
[3] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan
关键词
D O I
10.1074/jbc.M006412200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocyte growth factor activator (HGFA) is responsible for proteolytic activation of the precursor form of hepatocyte growth factor in injured tissues. To date, two specific inhibitors of HGFA have been identified, namely HGFA inhibitor type 1 (HAI-1) and type 2 (HAI-2)/placental bikunin (PB). Both inhibitors are first synthesized as integral membrane proteins having two Kunitz domains and a transmembrane domain, and are subsequently released from cell surface by shedding. Here we show that an active form of HGFA is specifically complexed with membrane-form HAI-1, but not with HAI-2/PB, on the surface of epithelial cells expressing both inhibitors. This binding required the enzyme activity of HGFA. The selective binding of HGFA to the cell surface HAI-1 was further confirmed in an engineered system using Chinese hamster ovary cells, in which only the cells expressing HAI-1 retained exogenous HGFA. The binding of HGFA to HAI-1 was reversible, and no irreversible modifications affecting the enzyme activity occurred during the binding. Importantly, HAI-1 and the HGFA HAI-1 complex were quickly released from the cell surface by treatment with phorbol 12-myristate 13-acetate or interleukin 1 beta accompanying the generation of 58-kDa fragments of HAI-1, which are less potent against HGFA, as well as significant recovery of HGFA activity in the culture supernatant. This regulated shedding was completely inhibited by BB3103, a synthetic zinc-metalloproteinase inhibitor. We conclude that HAI-1 is not only an inhibitor but also a specific acceptor of active HGFA, acting as a reservoir of this enzyme on the cell surface. The latter property appears to ensure the concentrated pericellular HGFA activity in certain cellular conditions, such as tissue injury and inflammation, via the up-regulated shedding of HGFA.HAI-1 complex. These findings shed light on a novel function of the integral membrane Kunitz-type inhibitor in the regulation of pericellular proteinase activity.
引用
收藏
页码:40453 / 40462
页数:10
相关论文
共 41 条
[1]   Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor [J].
Buxbaum, JD ;
Liu, KN ;
Luo, YX ;
Slack, JL ;
Stocking, KL ;
Peschon, JJ ;
Johnson, RS ;
Castner, BJ ;
Cerretti, DP ;
Black, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) :27765-27767
[2]   CHOLINERGIC AGONISTS AND INTERLEUKIN-1 REGULATE PROCESSING AND SECRETION OF THE ALZHEIMER BETA/A4 AMYLOID PROTEIN-PRECURSOR [J].
BUXBAUM, JD ;
OISHI, M ;
CHEN, HI ;
PINKASKRAMARSKI, R ;
JAFFE, EA ;
GANDY, SE ;
GREENGARD, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10075-10078
[3]   Characterization of placental bikunin, a novel human serine protease inhibitor [J].
Delaria, KA ;
Muller, DK ;
Marlor, CW ;
Brown, JE ;
Das, RC ;
Roczniak, SO ;
Tamburini, PP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (18) :12209-12214
[4]   Membrane protein secretases [J].
Hooper, NM ;
Karran, EH ;
Turner, AJ .
BIOCHEMICAL JOURNAL, 1997, 321 :265-279
[5]   Mouse hepatocyte growth factor activator gene: its expression not only in the liver but also in the gastrointestinal tract [J].
Itoh, H ;
Hamasuna, R ;
Kataoka, H ;
Yamauchi, M ;
Miyazawa, K ;
Kitamura, N ;
Koono, M .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2000, 1491 (1-3) :295-302
[6]   Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa [J].
Itoh, H ;
Kataoka, H ;
Tomita, M ;
Hamasuna, R ;
Nawa, Y ;
Kitamura, N ;
Koono, M .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2000, 278 (04) :G635-G643
[7]   Genomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genes [J].
Itoh, M ;
Yamauchi, M ;
Kataoka, H ;
Hamasuna, R ;
Kitamura, N ;
Koono, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (11) :3351-3359
[8]   Evaluation of hepatocyte growth factor activator inhibitor expression in normal and malignant colonic mucosa [J].
Kataoka, H ;
Uchino, H ;
Denda, K ;
Kitamura, N ;
Itoh, H ;
Tsubouchi, H ;
Nabeshima, K ;
Koono, M .
CANCER LETTERS, 1998, 128 (02) :219-227
[9]   Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues: Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues [J].
Kataoka, H ;
Suganuma, T ;
Shimomura, T ;
Itoh, H ;
Kitamura, N ;
Nabeshima, K ;
Koono, M .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1999, 47 (05) :673-682
[10]   Conserved expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin in human colorectal carcinomas [J].
Kataoka, H ;
Itoh, H ;
Uchino, H ;
Hamasuna, R ;
Kitamura, N ;
Nabeshima, K ;
Koono, M .
CANCER LETTERS, 2000, 148 (02) :127-134